<DOC>
	<DOCNO>NCT03030664</DOCNO>
	<brief_summary>A randomize , multicenter , placebo-controlled , double blind study two parallel group test efficacy daily oral supplementation probiotic L.reuteri DSM17938 compare placebo increase number spontaneous bowel movement infants child functional constipation .</brief_summary>
	<brief_title>Effect L. Reuteri Bowel Movements Children ( BIOWELL Study )</brief_title>
	<detailed_description>Functional constipation infant 4 year age define accord Rome III criterion ( Hyman 2006 ) . The diagnose must include 1 month least two follow criterion : two few defecation per week ; least 1 episode per week incontinence acquisition toilet skill ; history excessive stool retention ; history painful hard bowel movement ; presence large faecal mass rectum ; history large-diameter stool may obstruct toilet . Accompanying symptom may include irritability , decrease appetite and/or early satiety . The accompany symptom disappear immediately follow passage large stool . There grow interest use probiotic functional constipation research suggest probiotic could provide beneficial support traditional treatment arsenal although mechanisms action completely understood . Wu et al demonstrated Lactobacillus reuteri DSM 17938 may region-specific intestinal effect gut motility therefore could beneficial treatment constipation Lactobacillus reuteri DSM 17938 show significant favourable effect adult ( Ojetti 2014 ) young child describe ( Coccorullo 2010 , Olgac 2013 ) . These study require confirmation however . The present clinical study design strengthen current available data L. reuteri DSM 17938 beneficial effect infant young child functional constipation . We hypothesize daily oral supplementation probiotic Lactobacillus reuteri DSM 17938 effectively increase number spontaneous bowel movement infants/children diagnose functional constipation accord modify Rome III .</detailed_description>
	<mesh_term>Constipation</mesh_term>
	<criteria>Age : 6 month 4 year Suffering functional constipation , define modify Rome III criterion child age 4 year less ( Hyman 2006 ) Parent ( ) willingness postpone major change infant feed mode Parent ( ) willingness ability fill diary questionnaire Written inform consent parent Stated availability throughout study period Chronic illness major medical problem Gastrointestinal disease ( include organic cause constipation dyschezia history severe fecalome ) Intractable constipation ( respond conventional treatment 3 month ) Gastrointestinal surgery ( year enrolment ) Food allergy , lactose gluten intolerance , declare parent Use L. reuteri two week randomisation throughout intervention period . If feed infant formula , contain L. reuteri . Use antibiotic two week randomisation throughout intervention period , infant/child lactate mother If breastfeeding , use L reuteri mother 2 week prior enrolment Conventional treatment constipation within 2 week enrolment Medication influence gastrointestinal motility Mental behavioral disorder judge investigator</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>4 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>constipation</keyword>
	<keyword>Lactobacillus reuteri</keyword>
	<keyword>probiotic</keyword>
</DOC>